MD HB1101 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 8 2019 - 25% progression, died in committee
Action: 2019-02-19 - Hearing 3/08 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring the Maryland Department of Health to adopt certain regulations regarding the administration of mifepristone; requiring that mifepristone be provided by or under the supervision of a physician who meets certain qualifications and conditions; requiring each provider of mifepristone to make certain certifications and disclose certain information; establishing a certain penalty; requiring the Department to report to the General Assembly on or before December 1, 2019, and each December 1 thereafter; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health - Mifepristone - Administration

Sponsors


History

DateChamberAction
2019-02-19HouseHearing 3/08 at 1:00 p.m.
2019-02-08HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources


Bill Comments

feedback